Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
OtherBASIC SCIENCE INVESTIGATIONS

Modeling Spheroid Growth, PET Tracer Uptake, and Treatment Effects of the Hsp90 Inhibitor NVP-AUY922

Mats Bergstrom, Azita Monazzam, Pasha Razifar, Susan Ide, Raymond Josephsson and Bengt Langstrom
Journal of Nuclear Medicine July 2008, 49 (7) 1204-1210; DOI: https://doi.org/10.2967/jnumed.108.050799
Mats Bergstrom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Azita Monazzam
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pasha Razifar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susan Ide
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Raymond Josephsson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bengt Langstrom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 49 no. 7 1204-1210
DOI 
https://doi.org/10.2967/jnumed.108.050799
PubMed 
18552146

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication January 17, 2008
  • Accepted for publication March 18, 2008
  • Published online June 27, 2008.

Article Versions

  • previous version (June 13, 2008 - 08:18).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2008 by Society of Nuclear Medicine

Author Information

  1. Mats Bergstrom 1 , 2 ,
  2. Azita Monazzam 3 , 4 ,
  3. Pasha Razifar 4 ,
  4. Susan Ide 5 ,
  5. Raymond Josephsson 1 , 6 and
  6. Bengt Langstrom 4
  1. 1Clinical Imaging, Novartis Pharma AG, Basel, Switzerland; 2Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden; 3Department of Oncology, Uppsala University, Uppsala, Sweden; 4Uppsala Imanet, Uppsala, Sweden; 5Biomarker Development, Novartis Pharma, Boston, Massachusetts; and 6Department of Medical Sciences, Uppsala University, Uppsala, Sweden
  1. For correspondence or reprints contact: Mats Bergstrom, Clinical Imaging Centre, GlaxoSmithKline, Hammersmith, London, W12 0NN, U.K. E-mail: Mats.L.Bergstrom{at}GSK.com
View Full Text

Statistics from Altmetric.com

Cited By...

  • 16 Citations
  • 15 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • 89Zr-trastuzumab and 89Zr-bevacizumab PET to Evaluate the Effect of the HSP90 Inhibitor NVP-AUY922 in Metastatic Breast Cancer Patients
    Sietske B.M. Gaykema, Carolien P. Schröder, Joanna Vitfell-Rasmussen, Sue Chua, Thijs H. Oude Munnink, Adrienne H. Brouwers, Alfons H.H. Bongaerts, Mikhail Akimov, Cristina Fernandez-Ibarra, Marjolijn N. Lub-de Hooge, Elisabeth G.E. de Vries, Charles Swanton, Udai Banerji
    Clinical Cancer Research 2014 20 15
  • Radiopharmaceuticals in Preclinical and Clinical Development for Monitoring of Therapy with PET
    Mark P.S. Dunphy, Jason S. Lewis
    Journal of Nuclear Medicine 2009 50 Suppl 1
  • [18F]FLT: An imaging biomarker of tumour proliferation for assessment of tumour response to treatment
    Dmitry Soloviev, David Lewis, Davina Honess, Eric Aboagye
    European Journal of Cancer 2012 48 4
  • Current Challenges in Personalized Cancer Medicine
    Komal Jhaveri, Shanu Modi
    2012 65
  • A bioengineered 3D ovarian cancer model for the assessment of peptidase–mediated enhancement of spheroid growth and intraperitoneal spread
    Daniela Loessner, Simone C. Rizzi, Kathryn S. Stok, Tobias Fuehrmann, Brett Hollier, Viktor Magdolen, Dietmar W. Hutmacher, Judith A. Clements
    Biomaterials 2013 34 30
  • Adjoint method for a tumor growth PDE-constrained optimization problem
    D.A. Knopoff, D.R. Fernández, G.A. Torres, C.V. Turner
    Computers & Mathematics with Applications 2013 66 6
  • Combined expression of KLK4, KLK5, KLK6, and KLK7 by ovarian cancer cells leads to decreased adhesion and paclitaxel-induced chemoresistance
    Daniela Loessner, Verena M.C. Quent, Julia Kraemer, Eva C. Weber, Dietmar W. Hutmacher, Viktor Magdolen, Judith A. Clements
    Gynecologic Oncology 2012 127 3
  • Preclinical pharmacokinetic/pharmacodynamic models to predict synergistic effects of co-administered anti-cancer agents
    Kosalaram Goteti, C. Edwin Garner, Lucas Utley, Jing Dai, Susan Ashwell, Demetri T. Moustakas, Mithat Gönen, Gary K. Schwartz, Steven E. Kern, Sonya Zabludoff, Patrick J. Brassil
    Cancer Chemotherapy and Pharmacology 2010 66 2
  • FLT-PET Is Superior to FDG-PET for Very Early Response Prediction in NPM-ALK-Positive Lymphoma Treated with Targeted Therapy
    Zhoulei Li, Nicolas Graf, Ken Herrmann, Alexandra Jünger, Michaela Aichler, Annette Feuchtinger, Anja Baumgart, Axel Walch, Christian Peschel, Markus Schwaiger, Andreas Buck, Ulrich Keller, Tobias Dechow
    Cancer Research 2012 72 19
  • Molecular imaging of EGFR and CD44v6 for prediction and response monitoring of HSP90 inhibition in an in vivo squamous cell carcinoma model
    Diana Spiegelberg, Anja C. Mortensen, Ram K. Selvaraju, Olof Eriksson, Bo Stenerlöw, Marika Nestor
    European Journal of Nuclear Medicine and Molecular Imaging 2016 43 5

Article usage

Article usage: June 2008 to February 2023

AbstractFullPdf
Jun 200831134
Jul 2008483862
Aug 2008352226
Sep 2008372928
Oct 2008292315
Nov 2008341917
Dec 2008171210
Jan 2009251411
Feb 2009161916
Mar 2009201915
Apr 2009211613
May 200920710
Jun 20093566
Jul 2009202913
Aug 2009112715
Sep 2009132419
Oct 2009162520
Nov 2009251825
Dec 2009111411
Jan 201021912
Feb 201017189
Mar 20109129
Apr 2010151313
May 2010121811
Jun 201091815
Jul 201061813
Aug 2010161734
Sep 201041712
Oct 201071413
Nov 201015913
Dec 201010814
Jan 2011151211
Feb 201191510
Mar 2011151112
Apr 20112157
May 2011111112
Jun 201120209
Jul 20116811
Aug 2011241016
Sep 201114812
Oct 201119912
Nov 2011181213
Dec 2011231111
Jan 2012181417
Feb 201281515
Mar 2012182020
Apr 2012332823
May 2012421823
Jun 2012231417
Jul 2012221720
Aug 2012161712
Sep 2012252018
Oct 201271917
Nov 20122097
Dec 201216118
Jan 20131975
Feb 2013171413
Mar 2013151011
Apr 2013131418
May 2013171617
Jun 20131265
Jul 2013655
Aug 20131887
Sep 20131534
Oct 20131345
Nov 2013424
Dec 2013726
Jan 20141047
Feb 2014839
Mar 20143713
Apr 2014677
May 20149411
Jun 2014847
Jul 2014121316
Aug 20141034
Sep 201415109
Oct 2014181014
Nov 201410714
Dec 2014992
Jan 2015664
Feb 20151467
Mar 20152424
Apr 2015201013
May 20152386
Jun 20151466
Jul 201512156
Aug 20151654
Sep 201513512
Oct 2015627
Nov 20151997
Dec 201553711
Jan 20163598
Feb 20162035
Mar 201615212
Apr 20161823
May 20161421
Jun 20168214
Jul 20167221
Aug 201613510
Sep 20167818
Oct 20161139
Nov 20167910
Dec 2016943
Jan 2017559
Feb 2017321
Mar 20178122
Apr 2017401
May 2017510
Jun 20171120
Jul 2017372
Aug 2017947
Sep 20171055
Oct 2017746
Nov 20171072
Dec 2017151
Jan 2018956
Feb 2018341
Mar 2018412
Apr 2018832
May 2018854
Jun 2018311
Jul 2018702
Aug 2018651
Sep 2018382
Oct 2018483
Nov 2018353
Dec 2018420
Jan 2019663
Feb 2019341
Mar 2019339
Apr 20196110
May 20196315
Jun 20195211
Jul 2019709
Aug 2019605
Sep 2019411
Oct 2019816
Nov 2019505
Dec 20192783
Jan 20201555
Feb 2020624
Mar 2020827
Apr 2020112
May 2020234
Jun 2020704
Jul 2020411
Aug 2020714
Sep 2020624
Oct 20201125
Nov 2020462
Dec 2020576
Jan 20211102
Feb 20212119
Mar 2021868
Apr 2021252
May 20214105
Jun 20214152
Jul 20214114
Aug 202121410
Sep 2021295
Oct 202131811
Nov 202131016
Dec 20215135
Jan 20223157
Feb 2022573
Mar 20222149
Apr 2022056
May 202251217
Jun 2022056
Jul 20221144
Aug 2022287
Sep 202211120
Oct 2022177
Nov 2022294
Dec 20221104
Jan 2023111117
Feb 2023031
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 49 (7)
Journal of Nuclear Medicine
Vol. 49, Issue 7
July 2008
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Modeling Spheroid Growth, PET Tracer Uptake, and Treatment Effects of the Hsp90 Inhibitor NVP-AUY922
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Modeling Spheroid Growth, PET Tracer Uptake, and Treatment Effects of the Hsp90 Inhibitor NVP-AUY922
Mats Bergstrom, Azita Monazzam, Pasha Razifar, Susan Ide, Raymond Josephsson, Bengt Langstrom
Journal of Nuclear Medicine Jul 2008, 49 (7) 1204-1210; DOI: 10.2967/jnumed.108.050799

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Modeling Spheroid Growth, PET Tracer Uptake, and Treatment Effects of the Hsp90 Inhibitor NVP-AUY922
Mats Bergstrom, Azita Monazzam, Pasha Razifar, Susan Ide, Raymond Josephsson, Bengt Langstrom
Journal of Nuclear Medicine Jul 2008, 49 (7) 1204-1210; DOI: 10.2967/jnumed.108.050799
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • 17-Allylamino-17-demethoxygeldanamycin-induced Changes in [18F]Fluorothymidine Uptake
  • 89Zr-trastuzumab and 89Zr-bevacizumab PET to Evaluate the Effect of the HSP90 Inhibitor NVP-AUY922 in Metastatic Breast Cancer Patients
  • FLT-PET Is Superior to FDG-PET for Very Early Response Prediction in NPM-ALK-Positive Lymphoma Treated with Targeted Therapy
  • Radiopharmaceuticals in Preclinical and Clinical Development for Monitoring of Therapy with PET
  • Google Scholar

More in this TOC Section

  • Tumor Uptake of Anti-CD20 Fabs Depends on Tumor Perfusion
  • How Sensitive Is the Upper Gastrointestinal Tract to 90Y Radioembolization? A Histologic and Dosimetric Analysis in a Porcine Model
  • 11C-Methionine PET of Myocardial Inflammation in a Rat Model of Experimental Autoimmune Myocarditis
Show more Basic Science Investigations

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire